Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04341012 · ClinicalTrials.gov registry record

Breath Analysis Based Disease Biomarkers

A clinical trial of Covid19 and Liver Cancer, sponsored by Mayo Clinic.

Completed
Registry status
46
Enrollment target
1
Study location

NCT04341012 is a study of Covid19 and Liver Cancer that has completed, run by Mayo Clinic. The registered enrollment target is 46 participants, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04341012, a study of Covid19 and Liver Cancer, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
46 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to develop a clinical test based on breath analysis that can be used for disease diagnosis or prognosis.

Interventions

  • DIAGNOSTIC_TEST Collection of breath sample

Study Locations (1)

Florida

  • Mayo Clinic Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2019-09-10
Est. Completion 2021-09-03

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04341012

The ClinicalTrials.gov registry entry for NCT04341012 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which Collection of breath sample is the first listed.

NCT04341012 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04341012 about?

NCT04341012 is a clinical study titled "Breath Analysis Based Disease Biomarkers". The purpose of the study is to develop a clinical test based on breath analysis that can be used for disease diagnosis or prognosis.

What is the current status of trial NCT04341012?

This trial is currently completed. The enrollment target is 46 participants. The study started on 2019-09-10. Estimated completion is 2021-09-03.

What conditions does trial NCT04341012 study?

This clinical trial studies the following conditions: Covid19, Liver Cancer, Liver Diseases.

What interventions are being tested in trial NCT04341012?

The interventions under investigation include: Collection of breath sample (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04341012?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04341012 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Covid19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.